HEATHER BEGEMANN: Open Payments
NPI 1619216231 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 19 payments from 10 companies in 2025. Trend: 2023 $125 · 2024 $185 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 5 | $90 |
| Tandem Diabetes Care, Inc. | 3 | $48 |
| Dexcom, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Medtronic, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $14 |
Products named: iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, GVOKE HYPOPEN, MOUNJARO, Kerendia, MINIMED 780G, Wegovy.
Industry payments across MO — which companies pay providers there.
